|
    4568 Japan: Tokyo

    Daiichi Sankyo Co. Ltd.

    4568JP
    Closed
    Last Updated: Jun 9, 2023 3:00 p.m. JST Delayed quote

    ¥ 4,909

    169 3.57%
    Previous Close
    ¥4,740
    Advanced Charting
    Volume: 7.9M 65 Day Avg: 4.18M
    189% vs Avg
    4,806 Day Range 4,934
    3,013 52 Week Range 4,981

    Partner Center

    Your Watchlists

    Customize MarketWatch

    Have Watchlists? Log in to see them here or sign up to get started.

    Symbol
    Company
    Price
    Chg/Chg %
    No Items in Watchlist

    There are currently no items in this Watchlist.

    No Saved Watchlists

    Create a list of the investments you want to track.

    Uh oh

    Something went wrong while loading Watchlist.

    Recently Viewed Tickers

    No Recent Tickers

    Visit a quote page and your recently viewed tickers will be displayed here.

    4568 Overview

    Key Data

    • Open ¥4,831
    • Day Range 4,806 - 4,934
    • 52 Week Range 3,013 - 4,981
    • Market Cap ¥9.09T
    • Shares Outstanding 2.13B
    • Public Float 1.63B
    • Beta 0.88
    • Rev. per Employee ¥77.681M
    • P/E Ratio 86.26
    • EPS ¥57
    • Yield 0.69%
    • Dividend ¥15
    • Ex-Dividend Date Mar 30, 2023
    • Short Interest N/A
    • % of Float Shorted N/A
    • Average Volume 4.18M

    Performance

    5 Day
    • 4.20%
    1 Month
    • 6.72%
    3 Month
    • 11.11%
    YTD
    • 15.51%
    1 Year
    • 45.67%

    Analyst Ratings

    • Sell
    • Under
    • Hold
    • Over
    • Buy
    Number of Ratings 17 Full Ratings

    Recent News

    AstraZeneca Cancer Drug Enhertu Shows Clinically Meaningful, Durable Response in Trial

    Esperion’s stock tumbles after disclosing dispute about milestone payment

    Read full story

    AstraZeneca’s Breast Cancer Drug Beats Expectations, and Other ASCO Highlights

    Read full story

    Why AstraZeneca Could Be a Sound Long-Term Bet

    Read full story

    AstraZeneca Stock Climbs on ‘Groundbreaking’ Breast Cancer Drug Trial Results

    Read full story

    This chart is flashing an S&P warning from a slide for a key metal

    Read full story

    Hong Kong stocks tip into bear market as gambling shares crumble

    Read full story

    These corporate ties will be on display at Scott Gottlieb’s FDA commissioner confirmation hearing today

    Daiichi Sankyo Announces 50 Billion Yen Buyback: Why It’s Still Not A Buy

    Japan: How To Invest When Foreigners Are Fleeing

    Sun Pharma recalls Effexor in U.S. for second time

    Antidepressant drug fails in quality test

    Read full story

    Sun Pharma to buy Ranbaxy in $3.2 billion deal

    Read full story

    China leads Asia stocks lower

    Read full story

    Hong Kong stocks jump to lead broad Asia gains

    Read full story

    Most Asia markets end higher, led by Hong Kong

    Read full story

    Hong Kong stocks end off lows; Tokyo sags

    Read full story

    Tuesday’s biggest gaining and declining stocks

    Read full story

    Asia stocks mostly lower, with China dropping

    Read full story

    Asia stocks fall with exporters weak

    Bristol-Myers, Roche to study skin-cancer drugs

    NEW YORK -(MarketWatch)- Bristol-Myers Squibb Co. (BMY) and Roche Holding AG (RHHBY, ROG.VX) agreed to study how a combination of their melanoma drugs work in treating patients with a specific genetic mutation.

    T. Rowe Price Japan Fund Buys Daiichi Sankyo Co, SoftBank Group Corp, Plaid Inc, Sells Takeda ...

    T. Rowe Price Japan Fund Buys Daiichi Sankyo Co, SoftBank Group Corp, Plaid Inc, Sells Takeda Pharmaceutical Co, Welcia Holdings Co

    on GuruFocus.com

    Matthews Japan Fund Buys Yamato Holdings Co, Nissan Chemical Corp, Suntory Beverage & Food, ...

    Matthews Japan Fund Buys Yamato Holdings Co, Nissan Chemical Corp, Suntory Beverage & Food, Sells Fanuc Corp, Advantest Corp, Marui Group Co

    on GuruFocus.com

    Daiichi Sankyo Co. Ltd.

    Daiichi Sankyo Co., Ltd. engages in the research, development, manufacture, and sale of pharmaceuticals. Its products include drugs for the field of oncology such as Trastuzumab deruxtecan, Anti-HER3-ADC, Quizartinib, Milademetan, Valemetostat, Pexidartinib, Edoxaban, Prasugel, and Microgabalin. The company was founded on September 28, 2005 and is headquartered in Tokyo, Japan.

    Competitors

    Name Chg % Market Cap
    Takeda Pharmaceutical Co. Ltd. 1.25% ¥7.05T
    Chugai Pharmaceutical Co. Ltd. 2.59% ¥6.36T
    Shionogi & Co. Ltd. 0.94% ¥1.8T
    Sumitomo Pharma Co. Ltd. 2.36% ¥252.36B
    Hisamitsu Pharmaceutical Co. Inc. 0.98% ¥285.24B